Cti Biopharma Corp buy melinda
Start price
12.09.12
/
50%
€29.17
Target price
12.03.13
€40.00
Performance (%)
-66.68%
End price
12.03.13
€9.72
Summary
This prediction ended on 12.03.13 with a price of €9.72. Massive losses of -66.68% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cti Biopharma Corp | - | - | - | - |
| iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
| iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
| iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
| iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
Comments by melinda for this prediction
In the thread Cti Biopharma Corp diskutieren
Pixuvri
Cell Therapeutics hat angekündigt, dass das Unternehmen die bedingte Genehmigung für das Inverkehrbringen Pixuvri erhalten
(Laufzeit überschritten)
Stopped prediction by melinda for Cti Biopharma Corp
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€2.00
31.07.18
31.07.18
€2.71
30.10.19
30.10.19
-64.89%
30.10.19
30.10.19
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€10.03
22.05.13
22.05.13
€12.00
22.11.13
22.11.13
52.14%
22.11.13
22.11.13
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€45.75
20.01.12
20.01.12
€92.50
20.07.12
20.07.12
-49.62%
20.07.12
20.07.12